Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
暂无分享,去创建一个
Ewout W Steyerberg | Andrew J Vickers | Ben Van Calster | B. van Calster | E. Steyerberg | A. Vickers | B. Van calster
[1] Andrew J Vickers. Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers , 2008, The American statistician.
[2] Benjamin R Saville,et al. Decision curve analysis. , 2015, JAMA.
[3] Kim Pettersson,et al. Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Elena B. Elkin,et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers , 2008, BMC Medical Informatics Decis. Mak..
[5] Gary S Collins,et al. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 , 2012, BMJ : British Medical Journal.
[6] E. Steyerberg. Clinical Prediction Models , 2008, Statistics for Biology and Health.
[7] B. van Calster,et al. Calibration of Risk Prediction Models , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] Ewout W Steyerberg,et al. Decision Curve Analysis: A Discussion , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] Hester F. Lingsma,et al. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration , 2012, European journal of clinical investigation.
[10] E. Elkin,et al. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Jonathan Izawa,et al. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] K Claxton,et al. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.
[13] M. Pencina,et al. Evaluation of Markers and Risk Prediction Models , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] David I. Lee,et al. Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. , 2012, European urology.
[15] Ewout W. Steyerberg,et al. F1000Prime recommendation of Calibration of risk prediction models: impact on decision-analytic performance. , 2014 .
[16] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[17] E. Steyerberg,et al. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.
[18] Paul K J Han,et al. Validation of the Patient-Reported Outcome Mortality Prediction Tool (PROMPT). , 2015, Journal of pain and symptom management.
[19] Donna P Ankerst,et al. Prospective evaluation of operating characteristics of prostate cancer detection biomarkers. , 2011, The Journal of urology.
[20] Lori J Sokoll,et al. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. , 2014, Urology.
[21] S. Goodman,et al. Beyond the Usual Prediction Accuracy Metrics: Reporting Results for Clinical Decision Making , 2012, Annals of Internal Medicine.
[22] S. Duffy,et al. Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer , 2012, Annals of Internal Medicine.